Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma

NCT04152356 is registered in ClinicalTrials.gov with Guangxi Medical University as lead sponsor.

NCT NCT04152356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04152356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma
Lead sponsor
Guangxi Medical University
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2019
Completion date
September 1, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma